These glycan structures are ligated by mannose-binding lectins like DC-SIGN, that are expressed by cells in the tumor microenvironment, triggering continuous BCR signaling that aids in the progression and survival of the malignant B cells. This evidence concerns the gene CD209 and neoplasm.